Advocacy intelligence hub — real-time data for patient organizations
M.D. Anderson Cancer Center — PHASE2
Radboud University Medical Center — PHASE1
Karolinska University Hospital — EARLY_PHASE1
Hospices Civils de Lyon — PHASE2
National Health Research Institutes, Taiwan
UNC Lineberger Comprehensive Cancer Center — PHASE1
Zhejiang Provincial People's Hospital — PHASE1, PHASE2
West China Hospital — PHASE2
Grupo Espanol de Tumores Neuroendocrinos — PHASE2
Power Life Sciences Inc.
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Tafinlar Capsules and Mekinist Tablets
(dabrafenib and trametinib)Orphan drugstandardNovartis Pharmaceuticals Corporation
Mark Zafereo, MD
M.D. Anderson Cancer Center
📍 HOUSTON, TX
Maria E Cabanillas, M.D
M.D. Anderson Cancer Center
📍 HOUSTON, TX
Matthew Krebs, Dr
The Christie Hospital
Makoto Tahara, MD, PhD
National Cancer Center Hospital East
Sonal Gupta, MD PhD
AffyImmune Therapeutics, Inc.
Eric Sherman, MD
Memorial Sloan Kettering Cancer Center